A couple of days in the past week of approximately 4 million shares traded. I assume these are directed pre-arranged sales. Any guesses who is buying and who is selling?
Good news doesn't seem to be appreciated. $80 million in cash for a company with a $100 million market cap. Pfizer takes equity position and appears to "overpay." Great news on Fabry drug with huge market potential. NASH for liver disease. Other pipeline products to finish proof of concept trials by the end of this year. FDA meeting for Fabry drug within the next month or so. Amicus non-enzyme replacement Fabry drug delay. I don't understand the dropping price of the stock. I'm staying long. Maybe tax selling taking place?
I need help understanding today's news. Seems like PLX now has $80 million in cash with a market capitalization of $102 million. So if you back out the cash, the whole company is worth $22 million? Does this seem correct?
I have heard many of their scientific meetings and investor conferences over the past few years. They keep relating a very positive story. I would hate to think they were misrepresenting the facts but I share all of your concerns.
Amicus (FOLD) had bad news for their Fabry drug. Check it out. The stock is being crushed. Great timing for PLX. May be huge market opportunity. I hope the FDA wants to facilitate a new bio-better enzyme replacement therapy for the Fabry community. Approximately $1 Billion dollars per year spent on Fabry drugs from my understanding. More PLX news regarding Fabry trials is due out in the final quarter of this year (could be any day between now and year end).
I'm surprised the stock price has not risen more in response to hopeful ZTE court situation. I guess people would rather wait for a ruling. Such a low market cap that any significant settlement would cause the stock to bounce. I'm holding a position so I don't miss any move. I don't really view this as an investment but more as a bit of a gamble. Semantics but that's my mindset. I enjoy watching the news flow and really believe that the courts will ultimately recognize the value of patents and intellectual property so as not to discourage innovation.
63 cents. Take a shot with a few shares. Potential for a big pay day. Better odds than black or red. I would only commit money you can afford to lose. No point in selling now.
Good news out for Fabry. First potential bio-better with big market potential. The next few months will be interesting with good news flow.